Return On Equity of Viridian Therapeutics, Inc.\DE from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Viridian Therapeutics, Inc.\DE quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Viridian Therapeutics, Inc.\DE Return On Equity for the quarter ending 30 Sep 2025 was -53%, a 16% decline year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Return On Equity for 2024 was -43%, a 37% increase from 2023.
  • Viridian Therapeutics, Inc.\DE annual Return On Equity for 2023 was -68%, a 46% decline from 2022.
  • Viridian Therapeutics, Inc.\DE annual Return On Equity for 2022 was -47%, a 12% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Viridian Therapeutics, Inc.\DE Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -53% -7% -16% 01 Jul 2025 30 Sep 2025
Q2 2025 -55% -5% -11% 01 Apr 2025 30 Jun 2025
Q1 2025 -49% +5% +8.7% 01 Jan 2025 31 Mar 2025
Q4 2024 -43% +25% +37% 01 Oct 2024 31 Dec 2024
Q3 2024 -45% +19% +29% 01 Jul 2024 30 Sep 2024
Q2 2024 -50% +4% +7.8% 01 Apr 2024 30 Jun 2024
Q1 2024 -54% -1% -1.1% 01 Jan 2024 31 Mar 2024
Q4 2023 -68% -22% -46% 01 Oct 2023 31 Dec 2023
Q3 2023 -64% -14% -29% 01 Jul 2023 30 Sep 2023
Q2 2023 -54% +2% +3.9% 01 Apr 2023 30 Jun 2023
Q1 2023 -53% 0% -0.91% 01 Jan 2023 31 Mar 2023
Q4 2022 -47% +7% +12% 01 Oct 2022 31 Dec 2022
Q3 2022 -50% +57% +53% 01 Jul 2022 30 Sep 2022
Q2 2022 -56% +97% +63% 01 Apr 2022 30 Jun 2022
Q1 2022 -53% +128% +71% 01 Jan 2022 31 Mar 2022
Q4 2021 -53% +181% +77% 01 Oct 2021 31 Dec 2021
Q3 2021 -107% +35% +25% 01 Jul 2021 30 Sep 2021
Q2 2021 -153% +11% +6.8% 01 Apr 2021 30 Jun 2021
Q1 2021 -181% -26% -17% 01 Jan 2021 31 Mar 2021
Q4 2020 -234% -86% -58% 01 Oct 2020 31 Dec 2020
Q3 2020 -142% -29% -25% 01 Jul 2020 30 Sep 2020
Q2 2020 -165% -79% -92% 01 Apr 2020 30 Jun 2020
Q1 2020 -154% -82% -114% 01 Jan 2020 31 Mar 2020
Q4 2019 -148% -96% -185% 01 Oct 2019 31 Dec 2019
Q3 2019 -113% -65% -135% 01 Jul 2019 30 Sep 2019
Q2 2019 -86% -39% -82% 01 Apr 2019 30 Jun 2019
Q1 2019 -72% -21% -42% 01 Jan 2019 31 Mar 2019
Q4 2018 -52% +12% +18% 01 Oct 2018 31 Dec 2018
Q3 2018 -48% +109% +69% 01 Jul 2018 30 Sep 2018
Q2 2018 -47% +257% +85% 01 Apr 2018 30 Jun 2018
Q1 2018 -51% -2994% -102% 01 Jan 2018 31 Mar 2018
Q4 2017 -64% -226% -139% 01 Oct 2017 31 Dec 2017
Q3 2017 -157% -378% -171% 01 Jul 2017 30 Sep 2017
Q2 2017 -304% -601% -202% 01 Apr 2017 30 Jun 2017
Q1 2017 2943% +2575% +699% 01 Jan 2017 31 Mar 2017
Q4 2016 163% -366% -69% 01 Oct 2016 31 Dec 2016
Q3 2016 221% +320% 01 Jul 2016 30 Sep 2016
Q2 2016 297% 01 Apr 2016 30 Jun 2016
Q1 2016 368% 01 Jan 2016 31 Mar 2016
Q4 2015 529% 01 Oct 2015 31 Dec 2015
Q3 2015 -99% 01 Jul 2015 30 Sep 2015

Viridian Therapeutics, Inc.\DE Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -43% +25% +37% 01 Jan 2024 31 Dec 2024
2023 -68% -22% -46% 01 Jan 2023 31 Dec 2023
2022 -47% +7% +12% 01 Jan 2022 31 Dec 2022
2021 -53% +181% +77% 01 Jan 2021 31 Dec 2021
2020 -234% -86% -58% 01 Jan 2020 31 Dec 2020
2019 -148% -96% -185% 01 Jan 2019 31 Dec 2019
2018 -52% +12% +18% 01 Jan 2018 31 Dec 2018
2017 -64% -226% -139% 01 Jan 2017 31 Dec 2017
2016 163% -366% -69% 01 Jan 2016 31 Dec 2016
2015 529% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.